178 related articles for article (PubMed ID: 26873637)
1. Extremity soft tissue sarcoma with multiple primary malignancies--Characteristics and outcome.
Lopez-Oliva CL; Yun JY; Kim HS; Han I
Eur J Surg Oncol; 2016 Apr; 42(4):567-73. PubMed ID: 26873637
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Treatment Pattern of Extremity Soft Tissue Sarcoma in Korea, 2009-2011: A Nationwide Study Based on the Health Insurance Review and Assessment Service Database.
Kang S; Kim HS; Choi ES; Han I
Cancer Res Treat; 2015 Oct; 47(4):575-82. PubMed ID: 25687875
[TBL] [Abstract][Full Text] [Related]
3. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
Weitz J; Antonescu CR; Brennan MF
J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
[TBL] [Abstract][Full Text] [Related]
4. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
Trovik CS;
Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
[TBL] [Abstract][Full Text] [Related]
5. Soft-tissue Ewing sarcoma in a low-incidence population: comparison to skeletal Ewing sarcoma for clinical characteristics and treatment outcome.
Lee JA; Kim DH; Lim JS; Koh JS; Kim MS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
Jpn J Clin Oncol; 2010 Nov; 40(11):1060-7. PubMed ID: 20513751
[TBL] [Abstract][Full Text] [Related]
6. Improved prognosis in soft-tissue sarcoma of extremity and trunk wall.
Sampo MM; Klintrup K; Tukiainen EJ; Böhling TO; Blomqvist CP
Acta Orthop; 2017 Feb; 88(1):116-120. PubMed ID: 27321676
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.
Kang S; Han I; Lee S; Kim W; Kim H
Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741
[TBL] [Abstract][Full Text] [Related]
8. Outcome After Surgery for Extremity Soft Tissue Sarcoma in Patients Presenting With Metastasis at Diagnosis.
Krishnan CK; Kim HS; Park JW; Han I
Am J Clin Oncol; 2018 Jul; 41(7):681-686. PubMed ID: 27819879
[TBL] [Abstract][Full Text] [Related]
9. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
Choi ES; Kim HS; Han I
Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
11. Unplanned excision of soft tissue sarcoma results in increased rates of local recurrence despite full further oncological treatment.
Qureshi YA; Huddy JR; Miller JD; Strauss DC; Thomas JM; Hayes AJ
Ann Surg Oncol; 2012 Mar; 19(3):871-7. PubMed ID: 21792512
[TBL] [Abstract][Full Text] [Related]
12. An updated incidence trends of soft-tissue sarcoma and cancer-specific survival of patients with primary soft-tissue sarcoma of liver: a population-based study.
Zhang Y; Wu Z; Chang J; Jiang W; Wang Y; Wang H; Li J; Li C; Li X
Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):689-698. PubMed ID: 33115276
[No Abstract] [Full Text] [Related]
13. Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma.
Billingsley KG; Lewis JJ; Leung DH; Casper ES; Woodruff JM; Brennan MF
Cancer; 1999 Jan; 85(2):389-95. PubMed ID: 10023707
[TBL] [Abstract][Full Text] [Related]
14. Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group.
Bisogno G; Sotti G; Nowicki Y; Ferrari A; Garaventa A; Zanetti I; Favre C; Schiavetti A; Tamaro P; Carli M
Cancer; 2004 Apr; 100(8):1758-65. PubMed ID: 15073867
[TBL] [Abstract][Full Text] [Related]
15. New perspectives for staging and prognosis in soft tissue sarcoma.
Lahat G; Tuvin D; Wei C; Anaya DA; Bekele BN; Lazar AJ; Pisters PW; Lev D; Pollock RE
Ann Surg Oncol; 2008 Oct; 15(10):2739-48. PubMed ID: 18521685
[TBL] [Abstract][Full Text] [Related]
16. Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study.
Yoneda Y; Kunisada T; Naka N; Nishida Y; Kawai A; Morii T; Takeda K; Hasei J; Yamakawa Y; Ozaki T;
Eur J Surg Oncol; 2014 Jan; 40(1):49-54. PubMed ID: 24075825
[TBL] [Abstract][Full Text] [Related]
17. Head and neck soft tissue sarcomas: unique lack of significance of synchronous node metastases.
Smith VA; Overton LJ; Lentsch EJ
J Surg Oncol; 2012 Dec; 106(7):837-43. PubMed ID: 22605652
[TBL] [Abstract][Full Text] [Related]
18. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
Gustafson P
Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
[TBL] [Abstract][Full Text] [Related]
19. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity : a retrospective analysis.
Canter RJ; Qin LX; Downey RJ; Brennan MF; Singer S; Maki RG
Cancer; 2007 Nov; 110(9):2050-60. PubMed ID: 17828771
[TBL] [Abstract][Full Text] [Related]
20. Post-metastasis survival in extremity soft tissue sarcoma: a recursive partitioning analysis of prognostic factors.
Kang S; Kim HS; Kim S; Kim W; Han I
Eur J Cancer; 2014 Jun; 50(9):1649-56. PubMed ID: 24703898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
